These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6209293)

  • 1. Rapid high-performance liquid chromatographic method for the separation of the three types of gamma-chain of human fetal haemoglobin.
    Baudin V; Wajcman H
    J Chromatogr; 1984 Sep; 299(2):495-7. PubMed ID: 6209293
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of gamma-globin expression in hereditary persistence of fetal hemoglobin.
    Ottolenghi S; Nicolis S; Bertini C; Ronchi A; Crotta S; Giglioni B
    Ann N Y Acad Sci; 1990; 612():191-5. PubMed ID: 1705408
    [No Abstract]   [Full Text] [Related]  

  • 3. The polymorphism of human fetal hemoglobin.
    Huisman TH
    Birth Defects Orig Artic Ser; 1982; 18(7):83-99. PubMed ID: 6186316
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal haemoglobin, sickling, and thalassaemia: a therapeutic lead?
    Br Med J; 1978 Jul; 2(6129):3-4. PubMed ID: 678797
    [No Abstract]   [Full Text] [Related]  

  • 5. The M gamma chain of human fetal hemoglobin; its identification and occurrence.
    Huisman TH; Kutlar F; Kutlar A; Wilson JB; Harris HF
    J Chromatogr; 1987 Feb; 388(2):429-39. PubMed ID: 2435748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What determines severity in sickle-cell disease?
    Schechter AN; Bunn HF
    N Engl J Med; 1982 Feb; 306(5):295-7. PubMed ID: 6172711
    [No Abstract]   [Full Text] [Related]  

  • 7. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
    Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantification of Ggamma- and Agamma-globins by electrospray ionisation mass spectrometry.
    Ofori-Acquah SF; Green BN; Wild BJ; Lalloz MR; Layton DM
    Int J Mol Med; 1998 Oct; 2(4):451-3. PubMed ID: 9857233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the A gamma-globin promoter in hereditary persistence of fetal hemoglobin and delta beta zero-thalassemia.
    Ottolenghi S; Giglioni B; Comi P; Mantovani R; Malgaretti N; Nicolis S; Longinotti M; Sciarratta GV; Pirastu M; Camaschella C
    Prog Clin Biol Res; 1987; 251():373-82. PubMed ID: 2448807
    [No Abstract]   [Full Text] [Related]  

  • 10. Sickle cell anemia and fetal hemoglobin.
    Steinberg MH
    Am J Med Sci; 1994 Nov; 308(5):259-65. PubMed ID: 7526687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forty-four years (1955-1999) devoted to hemoglobin research: Titus H. J. Huisman (1923-1999).
    Efremov GD
    Hemoglobin; 2001 May; 25(2):125-68. PubMed ID: 11480778
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha thalassemia. A modifier of sickle cell disease.
    Embury SH
    Ann N Y Acad Sci; 1989; 565():213-21. PubMed ID: 2476060
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
    Adeyemo T; Ojewunmi O; Oyetunji A
    Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
    N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hemoglobin heterogeneity in Brazilian newborns and beta-thalassemia homozygotes.
    Zago MA
    Haematologica; 1989; 74(4):347-50. PubMed ID: 2477318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.
    Labie D; Pagnier J; Lapoumeroulie C; Rouabhi F; Dunda-Belkhodja O; Chardin P; Beldjord C; Wajcman H; Fabry ME; Nagel RL
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2111-4. PubMed ID: 2580306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of the percentages of G gamma and A gamma chains in human fetal hemoglobin by HPLC.
    Shimizu K; Wilson JB; Huisman TH
    Hemoglobin; 1980; 4(3-4):487-96. PubMed ID: 6158503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene switching -- a new therapeutic epoch: discussion paper.
    Nalbandian RM; Cypress GC
    J R Soc Med; 1984 Mar; 77(3):217-20. PubMed ID: 6199499
    [No Abstract]   [Full Text] [Related]  

  • 19. The increasing complexity of sickle cell anemia.
    Warth JA; Rucknagel DL
    Prog Hematol; 1983; 13():25-47. PubMed ID: 6199811
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.